Hydrocortisone Probutate

CHEMBL1200953 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
488.6 g/mol
LogP
4.2
Phase
4

A unique double-ester derivative of hydrocortisone designed to improve skin penetration and local anti-inflammatory potency while minimizing systemic absorption. It is used as a topical corticosteroid for inflammatory skin conditions. Once absorbed into the skin, it is metabolized to active hydrocortisone to exert its therapeutic effect.

น้ำหนักโมเลกุล

488.6000 g/mol

LogP

4.20

TPSA

107.00 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

กลไกการออกฤทธิ์

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C

InChI

InChI=1S/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1

Molecular Formula

C28H40O7

HBD / HBA

1 / 7

พันธะที่หมุนได้

9

อะตอมหนัก

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A unique double-ester derivative of hydrocortisone designed to improve skin penetration and local anti-inflammatory potency while minimizing systemic absorption. It is used as a topical corticosteroid for inflammatory skin conditions. Once absorbed into the skin, it is metabolized to active hydrocortisone to exert its therapeutic effect.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Hydrocortisone Probutate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200953. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 636398. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.